Introduction {#Sec1}
============

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory rheumatic disease with symptom onset in childhood and persists into adulthood in about 50% of the patients \[[@CR1], [@CR2]\].

Arterial stiffness is an established independent predictor of cardiovascular disease (CVD) \[[@CR3]\]. Whereas adult onset inflammatory arthritis is known to be related to increased arterial stiffness \[[@CR4]\], little is known of systemic arterial properties and cardiovascular risk in those with long-lasting JIA.

Pulse wave velocity (PWV) is the most frequently used method for the measurement of arterial stiffness reflecting large arterial stiffness \[[@CR5]\]. However, the properties of the arterial system can be described in more detail by use of system level parameters, as characteristic impedance (Z~0~), arterial compliance (C) and vascular resistance (R) \[[@CR6]\].

We have previously reported an increased prevalence of hypertension and arterial stiffness as measured by PWV in adults with long-lasting active JIA \[[@CR7]\]. However, Z~0~, C and R have hitherto not been described in this patient group. The present study was therefore designed to characterize systemic arterial properties in detail in JIA patients as compared to matched controls. We also wanted to assess the associations between JIA disease variables, cardiovascular risk factors and arterial properties.

Methods {#Sec2}
=======

Patients and controls {#Sec3}
---------------------

Totally 134 JIA patients with clinically active disease for at least 15 years of disease duration were invited to a combined rheumatologic and cardiologic follow-up study after median 29 years. The patients were initially referred to the Oslo University hospital between 1980 and 85, and re-examined after median 15 and 23 years before the present study \[[@CR2]\]. Between May 2011 and March 2012, 90 patients were included in the study. Nine were excluded after inclusion due to pregnancy (*n* = 3), recordings of suboptimal quality (*n* = 5), or severe heart disease without presumed relation to JIA (*n* = 1). The 81 participants were not different from the 53 eligible but not participating patients regarding gender, disease duration and age (data not shown).

Forty-six healthy, age- and gender-matched controls were selected randomly from the Norwegian population register. Responders with a history of diabetes mellitus, hypertension, or inflammatory arthritis were not included. Five were excluded after inclusion due to suboptimal recordings.

Clinical examination and cardiovascular risk assessments {#Sec4}
--------------------------------------------------------

The 81 patients underwent a clinical examination performed by a specialist in rheumatology, the controls were clinically examined by a physician.

JIA was classified according to the International League of Associations for Rheumatology criteria \[[@CR8]\]. Active disease was defined as the lack of remission off anti-rheumatic medication \[[@CR9]\].

Family history of CVD was defined as a first degree having CVD before the age of 65 (women) and 55 (men). Information about smoking habits and physical activity was obtained through a questionnaire. Insulin resistance was derived from the assessments of insulin and glucose \[[@CR10]\].

Three measurements of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with a difference of \< 5 mmHg were averaged and taken in all participants after 5 min rest in a supine position. Arterial hypertension was defined as SBP \> 140 mmHg and/or DBP \> 90 mmHg, and/or use of antihypertensive medication.

Blood samples were drawn after an overnight fast and analysed for high sensitive C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), insulin, glucose and cholesterol.

Non-invasive assessment of arterial properties {#Sec5}
----------------------------------------------

### Tonometry {#Sec6}

We recorded the arterial pulse waveform from the right common carotid artery with the patient in a supine position, using a high-fidelity external applanation tonometric device (Millar SPT-301, Millar Instruments Inc., Houston, USA). Recordings were obtained semi-simultaneously with echocardiographic doppler recordings (Vivid 7 ultrasound scanner, GE Vingmed ultrasound, Norway) of blood flow from the left ventricular outflow tract and the parasternal short axis midventricular cineloops. The tonometric signal was amplified and transferred to a personal computer for processing in Matlab 7 application \[[@CR11]\]. We selected at least three cardiac cycles for analysis. The carotid pulse trace peak and nadir were then calibrated with the systolic and diastolic brachial arterial pressures, respectively.

### Systemic arterial properties {#Sec7}

A 3-element electrical analogue Windkessel model of the systemic circulation was used to assess Z~0~, R and C \[[@CR11]\]. In order to obtain estimates of systemic parameters independent of any assumed model, we also assessed Z~0~ in the frequency domain as the average of the high frequency harmonics of the input impedance modulus \[[@CR6]\]. C was also estimated as stroke volume (mL) over arterial pulse pressure (mmHg).

### Statistics {#Sec8}

The JIA patients and controls, and the patient subgroups were compared using a 2-sided independent sample *t*-test for the continuous normally distributed variables, the Mann-Whitney *U*-test for the continuous not normally distributed values, and the χ^2^ test for the categorical variables. For the continuous normally distributed variables, central tendencies were given as the mean ± SD and for the continuous not normally distributed values, median inter-quartile range. A *p* value \< 0.05 (2 tailed) were regarded as statistically significant for all the analyses. Pearson's Correlation coefficients and multivariate linear regression analysis were used to investigate associations between disease variables, cardiovascular risk factors and arterial properties. SPSS Version 20 (SPSS, Chicago, USA) was used for the statistical analyses.

Results {#Sec9}
=======

Demographics and cardiovascular risk factors {#Sec10}
--------------------------------------------

The characteristics of patients and controls are summarized in Table [1](#Tab1){ref-type="table"}. Hypertension was present in 11% of the patients, and in none of the controls (*p* = 0.028).Table 1JIA disease characteristics and traditional cardiovascular risk factorsVariablesJIA patients (*n* = 81)Controls (*n* = 41)Demographics Male gender; n (%)20 (25)9 (22) Age (years); median (IQR)38.6 (34.9--40.7)37.7 (34.8--40.5) Disease duration (years); median (IQR)29.3 (28.3--30.6) Onset age (years); median (IQR)8.9 (4.9--11.8)JIA subtype distribution Systemic arthritis; n (%)4 (5) RF negative polyarthritis; n (%)11 (14) RF positive polyarthritis; n (%)5 (6) Persistent oligoarthritis; n (%)14 (17) Extended oligoarthritis; n (%)13 (16) Entesitis related arthritis; n (%)18 (22) Psoriatic arthritis; n (%)14 (17) Unclassified arthritis; n (%)2 (3)Current medication at 29-year follow-up Anti-TNF; n (%)25 (31) Metotrexat; n (%)19 (24) NSAIDs daily; n (%)23 (28) Prednisolone; n (%)5 (6.2)Cardiovascular risk factors BMI (kg/m^2^); mean (SD)25.7 (5.0)25.3 (3.9) Waist circumference (cm); mean (SD)92.7 (12.7)92.7 (9.0) Daily smokers; n (%)18 (22)5 (12) CVD in first degree relative; n (%)46 (57)19 (46) Hypertension; n (%)9 (11)0 (0)\* Myocardial infarction; n (%)1 (1)0 (0) Total cholesterol (mmol/L); mean (SD)4.9 (1.1)4.9 (0.8) LDL cholesterol (mmol/L); mean (SD)3.0 (1.0)3.0 (0.8) hs-CRP (mg/L); median (IQR)1.8 (0.7--5.0)0.7 (0.0--1.9)\* Insulin resistance1.1 (1.1)0.9 (0.6)*JIA* Juvenile idiopathic arthritis, *IQR* inter-quartile range, *RF* rheumatoid factor, anti-*TNF* anti-tumor necrosis factor, *NSAIDs* nonsteroidal anti-inflammatory drugs, *BMI* body mass index, *LDL* low density lipoprotein, *CVD* cardiovascular disease, *hs-CRP* high sensitivity C-reactive protein^\*^ *p* \< 0.05 compared with values in previous column

Systemic arterial properties {#Sec11}
----------------------------

Z~0~ estimated by Windkessel model was significantly higher (21.7%, *p* = 0.027, Table [2](#Tab2){ref-type="table"}) in the patients, and Z~0~ by frequency domain analyses although numerically higher in the patients, the difference was not statistically different between the groups. C by either of Windkessel model or ratio of stroke volume and pulse pressure was significantly lower in the patients compared to controls (12.8 and 9.8%, *p* = 0.030 and *p* = 0.038, respectively). Heart rate was slightly higher in the patients (*p* = 0.026), however R was similar in patients and controls.Table 2Arterial haemodynamics and arterial propertiesVariablesJIA Patients (*n* = 81)Controls (*n* = 41)Difference (%)*P*-valueHeight, cm170.5 (8.4)170.3 (8.3)00.881Weight, kg74.9 (16.7)73.3 (12.1)2.20.603Heart rate, beats/minute65 (11)61 (9)6.60.026Systolic blood pressure, mmHg119 (18)113 (11)5.30.054Diastolic blood pressure, mmHg70 (10)67 (9)4.50.091Mean arterial pressure; mmHg90 (13)85 (9)5.90.026R, mm Hg/ml/s1.02 (0.27)1.00 (0.22)0.020.636C WK, ml/ mm Hg1.57 (0.46)1.80 (0.65)12.80.030C SV/PP, ml/ mmHg1.29 (0.37)1.43 (0.34)9.80.038Z~0~ WK, 10^−3^ mmHg/ml/s65.0 (30.1)53.4 (18.8)21.70.027Z~0~ FD96.1 (37.2)91.5 (31.4)5.00.497Values are the mean (SD)*R* total peripheral resistance, *C WK* compliance estimated by Windkessel model, *C SV/PP* compliance estimated as ratio of stroke volume and pulse pressure, *Z*~*0*~ *WK* characteristic impedance estimated by Windkessel model, *Z*~*0*~ *FD* characteristic impedance estimated by frequency domain analyses

The association between JIA disease variables, cardiovascular risk factors and systemic arterial properties {#Sec12}
-----------------------------------------------------------------------------------------------------------

Z~0~ by Windkessel model was significantly higher in the patients with present or previous use of metotrexat, using prednisolone, and/or had polyarticular disease course as compared to the other patients (Fig. [1](#Fig1){ref-type="fig"}), and was correlated to higher ESR area under the curve (AUC), years on daily prednisolone and insulin resistance (Table [3](#Tab3){ref-type="table"}). When including these variables in a multiple linear regression analysis, years on daily prednisolone and insulin resistance were determinants of Z~0~ (ß = 0.003,*p* = 0.021, ß = 0.006,*p* = 0.042).Fig. 1The influence of JIA anti-rheumatic medication and JIA disease burden on systemic arterial properties; legends: JIA = Juvenile idiopathic arthritis, Z~0~ Windkessel model = characteristic impedance estimated by Windkessel modelTable 3Correlations of JIA disease variables, traditional cardiovascular risk factors and arterial properties assessed by Z~0~ Windkessel modelR*P*-valueJIA disease variables CRP area under the curve^a^0.0950.402 ESR area under the curve^a^0.2380.037 Years on daily prednisolone0.3460.002 Years on daily NSAIDs0.1520.177 Years on daily metotrexat0.0940.403 Disease duration−0.1930.085 JADAS−0.0840.465 Number of active joints0.0350.758Traditional cardiovascular risk factors Age−0.1170.296 BMI0.1800.108 Waist circumference0.2130.060 Insulin resistance0.2730.015 Daily smoking0.0720.526 Vigorous physical activity (hours/ week)−0.1110.347 Moderate physical activity (hours/ week)−0.1890.118Variables assessed at 29-year follow-up unless otherwise stated^a^Calculated from parameters assessed at 15-year and 29-year follow-up (CRP), disease onset, 15-year and 29-year follow-up (ESR)*JIA* juvenile idiopathic arthritis, *CRP* C-reactive protein, *ESR* erythrocyte sedimentation rate, *NSAIDs* nonsteroidal anti-inflammatory drugs, *JADAS* Juvenile Arthritis Disease Activity Score, *BMI* body mass index

Findings {#Sec13}
========

The present long-term follow-up study indicates that JIA patients with long-term active disease have altered systemic arterial properties as demonstrated by a higher Z~0~ by Windkessel and a lower C when compared to controls. Years on daily prednisolone and insulin resistance were the most important correlates of Z~0~. Furthermore, the use of metotrexat, polyarticular disease course and ESR AUC correlated with higher Z~0~.

Whereas Z~0~ reflects the combined effect of size and stiffness (a high Z~0~ implies a stiffer and/or small sized aorta) of predominantly the ascending aorta, C reflects the volume compliance of the entire systemic arterial tree. R is mainly determined by the small muscular arterioles \[[@CR6]\]. Considering both C and the Z~0~ by Windkessel, our findings suggest that the central conduit arteries are altered more than peripheral arteries in adult JIA patients. Previous reports have emphasized the importance of large arterial stiffness rather than alterations of microvascular resistance in the prediction of cardiovascular risk in patients with hypertension \[[@CR12], [@CR13]\]. Importantly, lower C and higher Z~0~ are associated with increased cardiovascular risk in the adult general population \[[@CR14], [@CR15]\].

Our data support a previous study from the same patient cohort, showing higher PWV in adult JIA patients compared to controls \[[@CR7]\]. Thus, increased arterial stiffness has been demonstrated to be present by different noninvasive techniques in JIA patients.

In the patient group, 8 had hypertension while controls with hypertension were excluded in order to maintain a healthy control group. However, when compared to controls, the differences in SBP and DBP were only marginal numerically, and not of statistical significance. Thus, we do not think that the difference in arterial properties between the JIA patients and controls can be fully explained by blood pressure variations. On the other hand, increased vascular stiffness predicts incident hypertension \[[@CR16]\] underscoring the bidirectional relationship between arterial properties and blood pressures. In our previous study not excluding hypertensive controls we found an increased prevalence of hypertension in the JIA patients as compared to the controls \[[@CR7]\].

We found an association between use of antirheumatic medication, polyarticular disease course and higher ESR AUC and insulin resistance and altered arterial properties. Larger prospective controlled studies are needed to identify determinants of altered arterial properties in JIA patients. Our findings add to the previously reported association between prednisolone use and increased arterial stiffness in JIA patients from our cohort \[[@CR7]\].

The strengths of this study are the inclusion of a well-defined cohort of JIA patients followed for 29 years and the fact that detailed information of arterial properties has not been presented in JIA patients before. However, the number of included participants was relatively small, and because of a cross sectional study design the prognostic value of our findings is unknown.

In conclusion, our results suggest that adult patients with long-lasting active JIA had stiffer proximal aorta, and lower total arterial compliance but similar systemic resistance compared to matched controls from the general population. Years on daily prednisolone and insulin resistance were the most important correlates of altered arterial properties. Whether our findings indicate that JIA patients should enter a regular BP monitoring program needs to be determined in future longitudinal follow-up studies.
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